Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding RNA - sirtuin - Sodium-glucose cotransporter-2 axis after myocardial infarction

2022/45/N/NZ7/02461

Keywords

Descriptors

  • NZ7_012: Prewencja chorób człowieka
  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Warszawski Uniwersytet Medyczny

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Anna Nowak-Szwed

Number of co-investigators in the project: 3

Call

PRELUDIUM 21 – announced on 2022-03-28

Amount awarded
208 866 PLN
Project start date
2023-02-15
Project end date
2026-02-14
Project duration
36 months (the same as in the proposal)
Project status
Project completed

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publications will be made available after the final report has been accepted.

« New search

Graphic design and implementation: Jakub Piotrowski